Cbio
Copenhagen, DK · 1 known investors
Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.
BiotechDeep TechHealthtech
Founders & leadership
J
JørgenCo-founder & Chief Operating Officer
JD
Jørgen DamFounder
Investors · 1
Frequently asked questions
- What does Cbio do?
- Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.
- Who founded Cbio?
- Cbio was founded by Jørgen.
- Who are Cbio's investors?
- Cbio's investors include Elmehøj Ventures.
- Where is Cbio headquartered?
- Cbio is headquartered in Copenhagen, DK.